VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.
暂无分享,去创建一个
D. Gillatt | S. Harper | D. Bates | M. Winkler | J. M. Doughty | T. Cui | M. Sugiono | D. Peat | J. Shields
[1] F. Erdoğan,et al. Prognostic significance of morphologic parameters in renal cell carcinoma , 2004, International journal of clinical practice.
[2] G. Gasparini,et al. Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. , 2001, Critical reviews in oncology/hematology.
[3] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[4] Stanley J. Wiegand,et al. Vascular-specific growth factors and blood vessel formation , 2000, Nature.
[5] G. Martiny-Baron,et al. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. , 2000, Cancer research.
[6] P E Thorpe,et al. Ultrastructural Localization of the Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) Receptor-2 (FLK-1, KDR) in Normal Mouse Kidney and in the Hyperpermeable Vessels Induced by VPF/VEGF-expressing Tumors and Adenoviral Vectors , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[7] V. Paradis,et al. Expression of vascular endothelial growth factor in renal cell carcinomas , 2000, Virchows Archiv.
[8] M. Ziche,et al. Quantitative RT-PCR Assay for VEGF Mrna in Human Tumors of the Kidney , 1999, The International journal of biological markers.
[9] S. Harper,et al. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. , 1999, Clinical science.
[10] P. Thelen,et al. Quantification by competitive quantitative RT-PCR of VEGF121 and VEGF165 in renal cell carcinoma. , 1999, Anticancer research.
[11] L. Jingjing,et al. Human Müller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor. , 1999, Investigative ophthalmology & visual science.
[12] P. Langton,et al. Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium. , 1999, American journal of physiology. Heart and circulatory physiology.
[13] Y. Fukushima,et al. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma. , 1999, European journal of cancer.
[14] G. Melino,et al. Two New p73 Splice Variants, γ and δ, with Different Transcriptional Activity , 1998, Journal of Experimental Medicine.
[15] Shay Soker,et al. Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.
[16] D. Nicol,et al. Vascular endothelial growth factor expression is increased in renal cell carcinoma. , 1997, The Journal of urology.
[17] G. Neufeld,et al. VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix* , 1997, The Journal of Biological Chemistry.
[18] N. Ferrara,et al. The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.
[19] Hung V. Nguyen,et al. The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*) , 1996, The Journal of Biological Chemistry.
[20] B. Keyt,et al. Identification of Vascular Endothelial Growth Factor Determinants for Binding KDR and FLT-1 Receptors , 1996, The Journal of Biological Chemistry.
[21] G. Palade,et al. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.
[22] B. Spiegelman,et al. Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF. , 1995, Biochimica et biophysica acta.
[23] D. Ruiter,et al. Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. , 1994, The Journal of biological chemistry.
[24] E. Manseau,et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. , 1993, The American journal of pathology.
[25] E. Manseau,et al. Vascular permeability factor mRNA and protein expression in human kidney. , 1992, Kidney international.
[26] J. Winer,et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. , 1991, Molecular endocrinology.
[27] P. Hermanek,et al. Evaluation of the new tumor, nodes and metastases classification of renal cell carcinoma. , 1990, The Journal of urology.
[28] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[29] N. Ferrara,et al. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.
[30] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[31] Arthur C. Guyton,et al. Handbook of Physiology—The Cardiovascular System , 1985 .
[32] N. Simionescu,et al. The Cardiovascular System , 1983 .
[33] F. Plum. Handbook of Physiology. , 1960 .
[34] G. Gasparini,et al. Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. , 2001, Critical reviews in oncology/hematology.
[35] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[36] Stanley J. Wiegand,et al. Vascular-specific growth factors and blood vessel formation , 2000, Nature.
[37] G. Martiny-Baron,et al. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. , 2000, Cancer research.
[38] P E Thorpe,et al. Ultrastructural Localization of the Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) Receptor-2 (FLK-1, KDR) in Normal Mouse Kidney and in the Hyperpermeable Vessels Induced by VPF/VEGF-expressing Tumors and Adenoviral Vectors , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[39] V. Paradis,et al. Expression of vascular endothelial growth factor in renal cell carcinomas , 2000, Virchows Archiv.
[40] M. Ziche,et al. Quantitative RT-PCR Assay for VEGF Mrna in Human Tumors of the Kidney , 1999, The International journal of biological markers.
[41] S. Harper,et al. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. , 1999, Clinical science.
[42] P. Thelen,et al. Quantification by competitive quantitative RT-PCR of VEGF121 and VEGF165 in renal cell carcinoma. , 1999, Anticancer research.
[43] L. Jingjing,et al. Human Müller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor. , 1999, Investigative ophthalmology & visual science.
[44] J. M. Doughty,et al. Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium. , 1999, The American journal of physiology.
[45] Y. Fukushima,et al. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma. , 1999, European journal of cancer.
[46] G. Melino,et al. Two New p73 Splice Variants, γ and δ, with Different Transcriptional Activity , 1998, Journal of Experimental Medicine.
[47] Shay Soker,et al. Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.
[48] D. Nicol,et al. Vascular endothelial growth factor expression is increased in renal cell carcinoma. , 1997, The Journal of urology.
[49] G. Neufeld,et al. VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix* , 1997, The Journal of Biological Chemistry.
[50] N. Ferrara,et al. The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.
[51] Hung V. Nguyen,et al. The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*) , 1996, The Journal of Biological Chemistry.
[52] B. Keyt,et al. Identification of Vascular Endothelial Growth Factor Determinants for Binding KDR and FLT-1 Receptors , 1996, The Journal of Biological Chemistry.
[53] G. Palade,et al. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.
[54] B. Spiegelman,et al. Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF. , 1995, Biochimica et biophysica acta.
[55] D. Ruiter,et al. Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. , 1994, The Journal of biological chemistry.
[56] E. Manseau,et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. , 1993, The American journal of pathology.
[57] E. Manseau,et al. Vascular permeability factor mRNA and protein expression in human kidney. , 1992, Kidney international.
[58] J. Winer,et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. , 1991, Molecular endocrinology.
[59] P. Hermanek,et al. Evaluation of the new tumor, nodes and metastases classification of renal cell carcinoma. , 1990, The Journal of urology.
[60] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[61] N. Ferrara,et al. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.
[62] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[63] Arthur C. Guyton,et al. Handbook of Physiology—The Cardiovascular System , 1985 .
[64] S. Fuhrman,et al. Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.